These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25109986)

  • 1. Aberrant redox homoeostasis and mitochondrial dysfunction in Rett syndrome.
    Müller M; Can K
    Biochem Soc Trans; 2014 Aug; 42(4):959-64. PubMed ID: 25109986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome.
    Grosser E; Hirt U; Janc OA; Menzfeld C; Fischer M; Kempkes B; Vogelgesang S; Manzke TU; Opitz L; Salinas-Riester G; Müller M
    Neurobiol Dis; 2012 Oct; 48(1):102-14. PubMed ID: 22750529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1.
    De Filippis B; Valenti D; de Bari L; De Rasmo D; Musto M; Fabbri A; Ricceri L; Fiorentini C; Laviola G; Vacca RA
    Free Radic Biol Med; 2015 Jun; 83():167-77. PubMed ID: 25708779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome.
    De Filippis B; Valenti D; Chiodi V; Ferrante A; de Bari L; Fiorentini C; Domenici MR; Ricceri L; Vacca RA; Fabbri A; Laviola G
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):889-901. PubMed ID: 25890884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction in the skeletal muscle of a mouse model of Rett syndrome (RTT): implications for the disease phenotype.
    Gold WA; Williamson SL; Kaur S; Hargreaves IP; Land JM; Pelka GJ; Tam PP; Christodoulou J
    Mitochondrion; 2014 Mar; 15():10-7. PubMed ID: 24613463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbed redox homeostasis and oxidative stress: Potential players in the developmental regression in Rett syndrome.
    Müller M
    Neurosci Biobehav Rev; 2019 Mar; 98():154-163. PubMed ID: 30639673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overshooting Subcellular Redox-Responses in Rett-Mouse Hippocampus during Neurotransmitter Stimulation.
    Festerling K; Can K; Kügler S; Müller M
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Mitochondrial Mass and Cytosolic Redox Imbalance in Hippocampal Astrocytes of a Mouse Model of Rett Syndrome: Subcellular Changes Revealed by Ratiometric Imaging of JC-1 and roGFP1 Fluorescence.
    Bebensee DF; Can K; Müller M
    Oxid Med Cell Longev; 2017; 2017():3064016. PubMed ID: 28894505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.
    Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant mitochondrial function in patient-derived neural cells from CDKL5 deficiency disorder and Rett syndrome.
    Jagtap S; Thanos JM; Fu T; Wang J; Lalonde J; Dial TO; Feiglin A; Chen J; Kohane I; Lee JT; Sheridan SD; Perlis RH
    Hum Mol Genet; 2019 Nov; 28(21):3625-3636. PubMed ID: 31518399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Dysfunction and Redox Imbalance as a Diagnostic Marker of "Free Radical Diseases".
    Georgieva E; Ivanova D; Zhelev Z; Bakalova R; Gulubova M; Aoki I
    Anticancer Res; 2017 Oct; 37(10):5373-5381. PubMed ID: 28982845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK; Bailey ME; Cobb SR
    Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of mitochondrial lesion in pathogenesis of sporadic rett syndrome].
    Meng H; Pan H; Qi Y
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):662-4. PubMed ID: 11798944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the Rho GTPase-activating toxin CNF1 on fibroblasts derived from Rett syndrome patients: A pilot study.
    Cittadini C; Germinario EAP; Maroccia Z; Cosentino L; Maselli V; Gambardella L; Giambenedetti M; Guidotti M; Travaglione S; Fallerini C; Renieri A; Marcillo DIE; Ricceri L; Fortini P; De Filippis B; Fiorentini C; Fabbri A
    J Cell Mol Med; 2023 May; 27(10):1315-1326. PubMed ID: 37078409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial reactive oxygen species production and elimination.
    Nickel A; Kohlhaas M; Maack C
    J Mol Cell Cardiol; 2014 Aug; 73():26-33. PubMed ID: 24657720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen exchange and energy metabolism in erythrocytes of Rett syndrome and their relationships with respiratory alterations.
    Ciaccio C; Di Pierro D; Sbardella D; Tundo GR; Curatolo P; Galasso C; Santarone ME; Casasco M; Cozza P; Cortelazzo A; Rossi M; De Felice C; Hayek J; Coletta M; Marini S
    Mol Cell Biochem; 2017 Feb; 426(1-2):205-213. PubMed ID: 28063007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome.
    Signorini C; Leoncini S; De Felice C; Pecorelli A; Meloni I; Ariani F; Mari F; Amabile S; Paccagnini E; Gentile M; Belmonte G; Zollo G; Valacchi G; Durand T; Galano JM; Ciccoli L; Renieri A; Hayek J
    Oxid Med Cell Longev; 2014; 2014():195935. PubMed ID: 24987493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome.
    Musokhranova U; Grau C; Vergara C; Rodríguez-Pascau L; Xiol C; Castells AA; Alcántara S; Rodríguez-Pombo P; Pizcueta P; Martinell M; García-Cazorla A; Oyarzábal A
    J Transl Med; 2023 Oct; 21(1):756. PubMed ID: 37884937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.